Help us: Donate
Follow us on:



Isabelle Schiffer on Clinical Rejuvenation at EARD2020

More needs to be done to get working therapies to the clinic.

Dr. Isabelle Schiffer at Ending Age-Related Diseases 2020Dr. Isabelle Schiffer at Ending Age-Related Diseases 2020

In this presentation given at Ending Age-Related Diseases 2020, Dr. Isabelle Schiffer of the Forever Healthy Foundation discusses the state of rejuvenation therapies and progress in bringing them into clinical practice. She discusses the rejuvenation market along with senotherapies, which target senescent cells in order to treat age-related diseases. This presentation featured the dasatinib + quercetin senolytic combination along with the supplement fisetin. As she explains, the problems with senolytics as a clinical therapy, as things stand today, are that there are no treatment protocols and no clinical endpoints.

Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension: YouTube Facebook Twitter Instagram Instagram Discord
Thank You!

No Comments
Write a comment:


Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.